Global Cytokine Release Syndrome Management market size is expected to reach $32.35 billion by 2030 at 6.3%, driven due to enhanced treatment precision and reduce side effects
Read MoreGlobal Cyclic Heavy Menstrual Bleeding market size is expected to reach $6.62.45 billion by 2030 at 6.6%, segmented as by polymenorrhea, hormonal treatments
Read MoreGlobal C-X-C Chemokine Receptor 4 (CXCR4) Antagonists market size is expected to reach $2.75 billion by 2030 at 9.1%, segmented as by bl-8040, oncology applications (leukemia, lymphoma)
Read MoreGlobal Cutaneous T-Cell Lymphoma market size is expected to reach $3.6.88 billion by 2030 at 6.8%, impact of growing lymphoma cases on the cutaneous t-cell lymphoma market
Read MoreGlobal Cutaneous Squamous Cell Carcinoma (CSCC) market size is expected to reach $10.35 billion by 2030 at 5.6%, growing awareness and advances in skin cancer care drive market growth
Read MoreGlobal Cutaneous Lupus Erythematosus market size is expected to reach $4.33 billion by 2030 at 11.6%, segmented as by acute, systemic lupus erythematosus (sle)-associated acle
Read MoreCustomized genetic testing market to reach $29.5 billion by 2030 at 15.8% CAGR, driven rising adoption of personalized medicine.
Read MoreCustom compounded therapy market to reach $8.56 billion by 2030 at 7.5% CAGR, driven growing demand for personalized medications.
Read MoreGlobal Eye Infections market size is expected to reach $10.24 billion by 2030 at 5.2%, rising prevalence of eye-related disorders to drive growth in the market
Read MoreGlobal Extreme Lateral Interbody Fusion (XLIF) Surgery market size is expected to reach $2.05 billion by 2030 at 5.5%, surge in rising incidence of spinal illnesses fueling the growth of the market due to aging populations and lifestyle factors
Read More